Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, Newark, 07103, USA.
Circulation. 2010 Nov 23;122(21):2170-82. doi: 10.1161/CIRCULATIONAHA.110.958033. Epub 2010 Nov 8.
Silent information regulator 1 (Sirt1), a class III histone deacetylase, retards aging and protects the heart from oxidative stress. We here examined whether Sirt1 is protective against myocardial ischemia/reperfusion (I/R).
Protein and mRNA expression of Sirt1 is significantly reduced by I/R. Cardiac-specific Sirt1(-/-) mice exhibited a significant increase (44±5% versus 15±5%; P=0.01) in the size of myocardial infarction/area at risk. In transgenic mice with cardiac-specific overexpression of Sirt1, both myocardial infarction/area at risk (15±4% versus 36±8%; P=0.004) and terminal deoxynucleotidyl transferase dUTP nick end labeling-positive nuclei (4±3% versus 10±1%; P<0.003) were significantly reduced compared with nontransgenic mice. In Langendorff-perfused hearts, the functional recovery during reperfusion was significantly greater in transgenic mice with cardiac-specific overexpression of Sirt1 than in nontransgenic mice. Sirt1 positively regulates expression of prosurvival molecules, including manganese superoxide dismutase, thioredoxin-1, and Bcl-xL, whereas it negatively regulates the proapoptotic molecules Bax and cleaved caspase-3. The level of oxidative stress after I/R, as evaluated by anti-8-hydroxydeoxyguanosine staining, was negatively regulated by Sirt1. Sirt1 stimulates the transcriptional activity of FoxO1, which in turn plays an essential role in mediating Sirt1-induced upregulation of manganese superoxide dismutase and suppression of oxidative stress in cardiac myocytes. Sirt1 plays an important role in mediating I/R-induced increases in the nuclear localization of FoxO1 in vivo.
These results suggest that Sirt1 protects the heart from I/R injury through upregulation of antioxidants and downregulation of proapoptotic molecules through activation of FoxO and decreases in oxidative stress.
沉默信息调节因子 1(Sirt1)是一种 III 类组蛋白去乙酰化酶,可延缓衰老并保护心脏免受氧化应激。我们在此研究了 Sirt1 是否对心肌缺血/再灌注(I/R)具有保护作用。
I/R 可显著降低 Sirt1 的蛋白和 mRNA 表达。心脏特异性 Sirt1(-/-)小鼠的心肌梗死/危险区面积显著增加(44±5%比 15±5%;P=0.01)。在心脏特异性过表达 Sirt1 的转基因小鼠中,心肌梗死/危险区面积(15±4%比 36±8%;P=0.004)和末端脱氧核苷酸转移酶 dUTP 缺口末端标记阳性核(4±3%比 10±1%;P<0.003)均显著减少。在 Langendorff 灌流心脏中,心脏特异性过表达 Sirt1 的转基因小鼠在再灌注期间的功能恢复明显大于非转基因小鼠。Sirt1 可正向调节包括锰超氧化物歧化酶、硫氧还蛋白-1 和 Bcl-xL 在内的生存促进分子的表达,而负向调节促凋亡分子 Bax 和 cleaved caspase-3。通过抗 8-羟基脱氧鸟苷染色评估 I/R 后的氧化应激水平,Sirt1 可负向调节。Sirt1 可刺激 FoxO1 的转录活性,而 FoxO1 在介导 Sirt1 诱导的锰超氧化物歧化酶上调和抑制心肌细胞氧化应激中发挥重要作用。Sirt1 在体内介导 I/R 诱导的 FoxO1 核定位增加中起重要作用。
这些结果表明,Sirt1 通过激活 FoxO 和降低氧化应激来上调抗氧化剂和下调促凋亡分子,从而对 I/R 损伤发挥保护作用。